2 recruiting, 1 completed. 2 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Post-COVID: new trials by email Literature Review of Post-COVID trials Research Report on Post-COVID
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19 Fluvoxamine, Placebo - Post-COVID, POST-Covid 19 | Phase 3 | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 160 | 2026-06-04 | 2026-06-09 |
| ACT for Mental Health in Neurological Disorders ACT-based group therapy - Neurological Disorders, Mental Health | Not applicable | Recruiting | Bielefeld University | 44 | 2024-12-01 | 2025-03-27 |
| ASAP - Assisted Immediate Augmented Post-/Long-COVID Plan for Patients Infected With COVID-19 Psychological and Physiological Assessments - Long-COVID, Post-COVID | Not applicable | Completed | Prof. Dr. Sonia Lippke | 192 | 2021-12-15 | 2026-04-15 |
Post-Acute COVID-19 Syndrome (2) · Anxiety Disorders (1) · Brain Injuries (1) · Depression (1) · Fatigue (1) · Mental Disorders (1) · Nervous System Diseases (1) · Psychological Well-Being (1) · Psychophysiologic Disorders (1)
COVID-19 (2) · Chronic Disease (2) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Disease Attributes (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Pneumonia (2) · Pneumonia, Viral (2) · Post-Infectious Disorders (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2)
Fluvoxamine (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Bielefeld University (1) · Prof. Dr. Sonia Lippke (1)
Germany (2) · Netherlands (1)
Katja Werheid, Prof (1) · Sonia Lippke, Prof. Dr. (1)